Jump to content Main menu Main menu move to sidebar hide Navigation Main page Contents Current events Random article About Wikipedia Contact us Contribute Help Learn to edit Community portal Recent changes Upload file Special pages Search Search Appearance Donate Create account Log in Personal tools Donate Create account Log in Pages for logged out editors learn more Contributions Talk CentralNotice Contents move to sidebar hide (Top) 1 History and etymology 2 Structure 3 Sources Toggle Sources subsection 3.1 Biosynthesis 3.2 Chemical synthesis 3.3 Degradation 4 Alanine world hypothesis 5 Physiological function Toggle Physiological function subsection 5.1 Glucose–alanine cycle 5.2 Link to diabetes 6 Chemical properties Toggle Chemical properties subsection 6.1 Free radical 7 References Toggle the table of contents Alanine 71 languages Afrikaans العربية Azərbaycanca تۆرکجه বাংলা 閩南語 / Bân-lâm-gí Беларуская Български བོད་ཡིག Bosanski Català Čeština Dansk Deutsch Eesti Ελληνικά Español Esperanto Euskara فارسی Français Galego 한국어 Հայերեն Hrvatski Bahasa Indonesia Italiano עברית ქართული Қазақша Kurdî Latina Latviešu Lëtzebuergesch Lietuvių Magyar Македонски Bahasa Melayu Монгол Nederlands 日本語 Norsk bokmål Norsk nynorsk Occitan Oʻzbekcha / ўзбекча پښتو Polski Português Română Русский Sicilianu Simple English Slovenčina Slovenščina Српски / srpski Srpskohrvatski / српскохрватски Sunda Suomi Svenska Tagalog தமிழ் ไทย Тоҷикӣ Türkçe Українська Tiếng Việt Winaray 吴语 Yorùbá 粵語 中文 Edit links Article Talk English Read Edit View history Tools Tools move to sidebar hide Actions Read Edit View history General What links here Related changes Upload file Permanent link Page information Cite this page Get shortened URL Download QR code Print/export Download as PDF Printable version In other projects Wikimedia Commons Wikidata item Appearance move to sidebar hide From Wikipedia, the free encyclopedia Α-amino acid that is used in the biosynthesis of proteins Not to be confused with the chemical compound Allantoin , or the phenyl compound Aniline .

Alanine Alanine in non-ionic form Skeletal formula of L -alanine (neutral form) Ball-and-stick model (zwitterionic form) Space-filling model (zwitterionic form) Names IUPAC name Alanine [ 1 ] Systematic IUPAC name 2-Aminopropanoic acid Other names Alanic acid Alaninic acid 2-Aminopropionic acid Identifiers CAS Number L: 56-41-7 Y D/L: 302-72-7 Y D: 338-69-2 Y 3D model ( JSmol ) L: Interactive image D: Interactive image L Zwitterion : Interactive image D Zwitterion : Interactive image Beilstein Reference 1720248 ChEBI L: CHEBI:16977 Y D/L: CHEBI:16449 D: CHEBI:15570 ChEMBL L: ChEMBL279597 Y ChemSpider L: 5735 Y D/L: 582 Y D: 64234 Y DrugBank L: DB00160 ECHA InfoCard 100.000.249 EC Number L: 206-126-4 Gmelin Reference 49628 IUPHAR/BPS L: 720 KEGG L: C00041 Y D/L: C01401 D: C00133 PubChem CID L: 5950 D/L: 602 D: 71080 UNII L: OF5P57N2ZX Y D/L: 1FU7983T0U Y D: E3UDS4613U Y CompTox Dashboard ( EPA ) L: DTXSID20873899 InChI InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1 Key: QNAYBMKLOCPYGJ-REOHCLBHSA-N Y D/L: Key: QNAYBMKLOCPYGJ-UHFFFAOYSA-N D: Key: QNAYBMKLOCPYGJ-UWTATZPHSA-N SMILES L: C[C@@H](C(=O)O)N D: C[C@H](C(=O)O)N L Zwitterion : C[C@@H](C(=O)[O-])[NH3+] D Zwitterion : C[C@H](C(=O)[O-])[NH3+] Properties Chemical formula C 3 H 7 N O 2 Molar mass 89.094 g·mol −1 Appearance white powder Density 1.424 g/cm 3 Melting point 258 °C (496 °F; 531 K) (sublimes) Solubility in water 167.2 g/L (25 °C) log P −0.68 [ 2 ] Acidity (p K a ) 2.34 (carboxyl; H 2 O) 9.87 (amino; H 2 O) [ 3 ] Magnetic susceptibility (χ) −50.5 × 10 −6 cm 3 /mol Supplementary data page Alanine (data page) Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Infobox references Chemical compound Spin view of ball-stick model Alanine (symbol Ala or A ), [ 4 ] or α-alanine , is an α- amino acid that is used in the biosynthesis of proteins . It contains an amine group and a carboxylic acid group , both attached to the central carbon atom which also carries a methyl group side chain.  Consequently it is classified as a non-polar , aliphatic α-amino acid. Under biological conditions, it exists in its zwitterionic form with its amine group protonated (as −NH + 3 ) and its carboxyl group deprotonated (as −CO − 2 ).  It is non-essential to humans as it can be synthesized metabolically and does not need to be present in the diet. It is encoded by all codons starting with G C (GC U , GCC, GC A , and GCG).

The L - isomer of alanine ( left-handed ) is the one that is incorporated into proteins.

L -alanine is second only to L -leucine in rate of occurrence, accounting for 7.8% of the primary structure in a sample of 1,150 proteins .

[ 5 ] The right-handed form, D -alanine, occurs in peptides in some bacterial cell walls [ 6 ] : 131 (in peptidoglycan ) and in some peptide antibiotics , and occurs in the tissues of many crustaceans and molluscs as an osmolyte .

[ 7 ] History and etymology [ edit ] Alanine was first synthesized in 1850 when Adolph Strecker combined acetaldehyde and ammonia with hydrogen cyanide .

[ 8 ] [ 9 ] [ 10 ] The amino acid was named Alanin in German, in reference to aldehyde , with the interfix -an- for ease of pronunciation, [ 11 ] the German ending -in used in chemical compounds being analogous to English -ine .

Structure [ edit ] Alanine is an aliphatic amino acid, because the side-chain connected to the α-carbon atom is a methyl group (-CH 3 ). Alanine is the simplest α-amino acid after glycine . The methyl side-chain of alanine is non-reactive and is therefore hardly ever directly involved in protein function.

[ 12 ] Alanine is a nonessential amino acid , meaning it can be manufactured by the human body, and does not need to be obtained through the diet. Alanine is found in a wide variety of foods, but is particularly concentrated in meats.

Sources [ edit ] Biosynthesis [ edit ] Alanine can be synthesized from pyruvate and branched chain amino acids such as valine , leucine , and isoleucine .

Alanine is produced by reductive amination of pyruvate , a two-step process. In the first step, α-ketoglutarate , ammonia and NADH are converted by glutamate dehydrogenase to glutamate , NAD + and water. In the second step, the amino group of the newly formed glutamate is transferred to pyruvate by an aminotransferase enzyme, regenerating the α-ketoglutarate, and converting the pyruvate to alanine. The net result is that pyruvate and ammonia are converted to alanine, consuming one reducing equivalent .

[ 6 ] : 721 Because transamination reactions are readily reversible and pyruvate is present in all cells, alanine can be easily formed and thus has close links to metabolic pathways such as glycolysis , gluconeogenesis , and the citric acid cycle .

[ 13 ] Chemical synthesis [ edit ] See also: Hell–Volhard–Zelinsky halogenation L -Alanine is produced industrially by decarboxylation of L -aspartate by the action of aspartate 4-decarboxylase .  Fermentation routes to L -alanine are complicated by alanine racemase .

[ 14 ] Racemic alanine can be prepared by the condensation of acetaldehyde with ammonium chloride in the presence of sodium cyanide by the Strecker reaction , [ 15 ] or by the ammonolysis of 2-bromopropanoic acid .

[ 16 ] Degradation [ edit ] Alanine is broken down by oxidative deamination , the inverse reaction of the reductive amination reaction described above, catalyzed by the same enzymes. The direction of the process is largely controlled by the relative concentration of the substrates and products of the reactions involved.

[ 6 ] : 721 Alanine world hypothesis [ edit ] Alanine is one of the twenty canonical α-amino acids used as building blocks (monomers) for the ribosome-mediated biosynthesis of proteins. Alanine is believed to be one of the earliest amino acids to be included in the genetic code standard repertoire.

[ 17 ] [ 18 ] [ 19 ] [ 20 ] On the basis of this fact the "alanine world" hypothesis was proposed.

[ 21 ] This hypothesis explains the evolutionary choice of amino acids in the repertoire of the genetic code from a chemical point of view. In this model the selection of monomers (i.e. amino acids) for ribosomal protein synthesis is rather limited to those alanine derivatives that are suitable for building α-helix or β-sheet secondary structural elements. Dominant secondary structures in life as we know it are α-helices and β-sheets and most canonical amino acids can be regarded as chemical derivatives of alanine. Therefore, most canonical amino acids in proteins can be exchanged with alanine by point mutations while the secondary structure remains intact. The fact that alanine mimics the secondary structure preferences of the majority of the encoded amino acids is practically exploited in alanine scanning mutagenesis. In addition, classical X-ray crystallography often employs the polyalanine-backbone model [ 22 ] to determine three-dimensional structures of proteins using molecular replacement —a model-based phasing method.

Physiological function [ edit ] Glucose–alanine cycle [ edit ] In mammals, alanine plays a key role in glucose–alanine cycle between tissues and liver. In muscle and other tissues that degrade amino acids for fuel, amino groups are collected in the form of glutamate by transamination . Glutamate can then transfer its amino group to pyruvate , a product of muscle glycolysis , through the action of alanine aminotransferase , forming alanine and α-ketoglutarate . The alanine enters the bloodstream, and is transported to the liver. The alanine aminotransferase reaction takes place in reverse in the liver, where the regenerated pyruvate is used in gluconeogenesis , forming glucose which returns to the muscles through the circulation system. Glutamate in the liver enters mitochondria and is broken down by glutamate dehydrogenase into α-ketoglutarate and ammonium , which in turn participates in the urea cycle to form urea which is excreted through the kidneys.

[ 23 ] The glucose–alanine cycle enables pyruvate and glutamate to be removed from muscle and safely transported to the liver. Once there, pyruvate is used to regenerate glucose, after which the glucose returns to muscle to be metabolized for energy: this moves the energetic burden of gluconeogenesis to the liver instead of the muscle, and all available ATP in the muscle can be devoted to muscle contraction.

[ 23 ] It is a catabolic pathway, and relies upon protein breakdown in the muscle tissue. Whether and to what extent it occurs in non-mammals is unclear.

[ 24 ] [ 25 ] Link to diabetes [ edit ] Alterations in the alanine cycle that increase the levels of serum alanine aminotransferase (ALT) are linked to the development of type II diabetes.

[ 26 ] Chemical properties [ edit ] ( S )-Alanine (left) and ( R )-alanine (right) in zwitterionic form at neutral pH Alanine is useful in loss of function experiments with respect to phosphorylation . Some techniques involve creating a library of genes, each of which has a point mutation at a different position in the area of interest, sometimes even every position in the whole gene: this is called "scanning mutagenesis". The simplest method, and the first to have been used, is so-called alanine scanning , where every position in turn is mutated to alanine.

[ 27 ] Hydrogenation of alanine gives the amino alcohol alaninol , which is a useful chiral building block.

Free radical [ edit ] The deamination of an alanine molecule produces the free radical CH 3 C • HCO 2 − . Deamination can be induced in solid or aqueous alanine by radiation that causes homolytic cleavage of the carbon–nitrogen bond.

[ 28 ] This property of alanine is used in dosimetric measurements in radiotherapy .  When normal alanine is irradiated, the radiation causes certain alanine molecules to become free radicals, and, as these radicals are stable, the free radical content can later be measured by electron paramagnetic resonance in order to find out how much radiation the alanine was exposed to.

[ 29 ] This is considered to be a biologically relevant measure of the amount of radiation damage that living tissue would suffer under the same radiation exposure.

[ 29 ] Radiotherapy treatment plans can be delivered in test mode to alanine pellets, which can then be measured to check that the intended pattern of radiation dose is correctly delivered by the treatment system.

[ 30 ] References [ edit ] ^ International Union of Pure and Applied Chemistry (2014).

Nomenclature of Organic Chemistry: IUPAC Recommendations and Preferred Names 2013 .

The Royal Society of Chemistry . p. 1392.

doi : 10.1039/9781849733069 .

ISBN 978-0-85404-182-4 .

^ "L-alanine MSDS" .

ChemSrc .

^ Haynes WM, ed. (2016).

CRC Handbook of Chemistry and Physics (97th ed.).

CRC Press . pp.

5– 88.

ISBN 978-1-4987-5428-6 .

^ "Nomenclature and Symbolism for Amino Acids and Peptides" .

IUPAC - IUB Joint Commission on Biochemical Nomenclature. 1983. Archived from the original on 9 October 2008 . Retrieved 5 March 2018 .

^ Doolittle RF (1989).

"Redundancies in Protein Sequences" . In Fasman GD (ed.).

Prediction of Protein Structures and the Principles of Protein Conformation . New York: Plenum . pp.

599– 623.

ISBN 978-0-306-43131-9 .

^ a b c Mathews CK, Van Holde KE, Ahern KG (2000).

Biochemistry (3rd ed.). San Francisco, CA: Benjamin/Cummings Publishing .

ISBN 978-0-8053-3066-3 .

OCLC 42290721 .

^ Yoshikawa N, Sarower MG, Abe H (2016).

"Alanine Racemase and D-Amino Acid Oxidase in Aquatic Animals" . In Yoshimura T, Nishikawa T, Homma H (eds.).

D-Amino Acids: Physiology, Metabolism, and Application .

Springer Japan . pp.

269– 282.

ISBN 978-4-431-56077-7 .

^ Strecker A (1850).

"Ueber die künstliche Bildung der Milchsäure und einen neuen, dem Glycocoll homologen Körper" [On the artificial formation of lactic acid and a new substance homologous to glycine].

Annalen der Chemie und Pharmacie (in German).

75 (1): 27– 45.

doi : 10.1002/jlac.18500750103 .

Strecker names alanine on p. 30.

^ Strecker A (1854).

"Ueber einen neuen aus Aldehyd – Ammoniak und Blausäure entstehenden Körper" [On a new substance arising from acetaldehyde–ammonia [i.e., 1-aminoethanol] and hydrocyanic acid].

Annalen der Chemie und Pharmacie (in German).

91 (3): 349– 351.

doi : 10.1002/jlac.18540910309 .

^ "Alanine" .

AminoAcidsGuide.com . 10 June 2018 . Retrieved 14 April 2019 .

^ "Alanine" .

Oxford Dictionaries . Archived from the original on December 24, 2014 . Retrieved 2015-12-06 .

^ Patna BK, Kara TC, Ghosh SN, Dalai AK, eds. (2012).

Textbook of Biotechnology . McGraw-Hill Education.

ISBN 978-0-07-107007-2 .

^ Melkonian, Erica A.; Asuka, Edinen; Schury, Mark P. (2023), "Physiology, Gluconeogenesis" , StatPearls , Treasure Island (FL): StatPearls Publishing, PMID 31082163 , retrieved 2023-07-09 ^ Drauz K, Grayson IG, Kleemann A, Krimmer HP, Leuchtenberger W, Weckbecker C (2006).

Ullmann's Encyclopedia of Industrial Chemistry . Weinheim: Wiley-VCH.

doi : 10.1002/14356007.a02_057.pub2 .

ISBN 978-3-527-30673-2 .

^ Kendall EC, McKenzie BF (1929).

" dl -Alanine" .

Organic Syntheses .

9 : 4.

doi : 10.15227/orgsyn.009.0004 ; Collected Volumes , vol. 1, p. 21 ..

^ Tobie WC, Ayres GB (1941).

" dl -Alanine" .

Organic Syntheses .

doi : 10.15227/orgsyn.009.0004 ; Collected Volumes , vol. 1, p. 21 .

^ Trifonov EN (December 2000). "Consensus temporal order of amino acids and evolution of the triplet code".

Gene .

261 (1): 139– 51.

doi : 10.1016/S0378-1119(00)00476-5 .

PMID 11164045 .

^ Higgs PG, Pudritz RE (June 2009). "A thermodynamic basis for prebiotic amino acid synthesis and the nature of the first genetic code".

Astrobiology .

9 (5): 483– 90.

arXiv : 0904.0402 .

Bibcode : 2009AsBio...9..483H .

doi : 10.1089/ast.2008.0280 .

PMID 19566427 .

S2CID 9039622 .

^ Kubyshkin V, Budisa N (November 2019).

"The Alanine World Model for the Development of the Amino Acid Repertoire in Protein Biosynthesis" .

International Journal of Molecular Sciences .

20 (21): 5507.

doi : 10.3390/ijms20215507 .

PMC 6862034 .

PMID 31694194 .

^ Ntountoumi C, Vlastaridis P, Mossialos D, Stathopoulos C, Iliopoulos I, Promponas V, et al. (November 2019).

"Low complexity regions in the proteins of prokaryotes perform important functional roles and are highly conserved" .

Nucleic Acids Research .

47 (19): 9998– 10009.

doi : 10.1093/nar/gkz730 .

PMC 6821194 .

PMID 31504783 .

^ Kubyshkin V, Budisa N (December 2019).

"Anticipating alien cells with alternative genetic codes: away from the alanine world!" .

Current Opinion in Biotechnology .

60 : 242– 249.

doi : 10.1016/j.copbio.2019.05.006 .

PMID 31279217 .

^ Karmali AM, Blundell TL, Furnham N (February 2009).

"Model-building strategies for low-resolution X-ray crystallographic data" .

Acta Crystallographica. Section D, Biological Crystallography .

65 (Pt 2): 121– 7.

Bibcode : 2009AcCrD..65..121K .

doi : 10.1107/S0907444908040006 .

PMC 2631632 .

PMID 19171966 .

^ a b Nelson DL, Cox MM (2005).

Principles of Biochemistry (4th ed.). New York: W. H. Freeman. pp.

684– 85.

ISBN 0-7167-4339-6 .

.

^ Fish Physiology: Nitrogen Excretion . Academic Press. 2001-09-07. p. 23.

ISBN 978-0-08-049751-8 .

^ Walsh PJ, Wright PA (1995-08-31).

Nitrogen Metabolism and Excretion . CRC Press.

ISBN 978-0-8493-8411-0 .

^ Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, et al. (November 2004).

"Elevated Alanine Aminotransferase Predicts New-Onset Type 2 Diabetes Independently of Classical Risk Factors, Metabolic Syndrome, and C-Reactive Protein in the West of Scotland Coronary Prevention Study" .

Diabetes .

53 (11): 2855– 60.

doi : 10.2337/diabetes.53.11.2855 .

PMID 15504965 .

^ Park SJ, Cochran JR (2009-09-25).

Protein Engineering and Design . CRC Press.

ISBN 978-1-4200-7659-2 .

^ Zagórski ZP, Sehested K (1998). "Transients and Stable Radical from the Deamination of α-Alanine".

J. Radioanal. Nucl. Chem.

232 ( 1– 2): 139– 41.

Bibcode : 1998JRNC..232..139Z .

doi : 10.1007/BF02383729 .

S2CID 97855573 .

.

^ a b Andreo P, Burns DT, Nahum AE, Seuntjens J, Attix FH (2017).

"Alanine Dosimetry" .

Fundamentals of Ionizing Radiation Dosimetry (2nd ed.). Weinheim, Germany: Wiley-VCH . pp.

547– 556.

ISBN 978-3-527-80823-6 .

OCLC 990023546 .

^ Biglin, Emma R.; Aitkenhead, Adam H.; Price, Gareth J.; Chadwick, Amy L.; Santina, Elham; Williams, Kaye J.; Kirkby, Karen J. (2022-04-26).

"A preclinical radiotherapy dosimetry audit using a realistic 3D printed murine phantom" .

Scientific Reports .

12 (1): 6826.

Bibcode : 2022NatSR..12.6826B .

doi : 10.1038/s41598-022-10895-5 .

ISSN 2045-2322 .

PMC 9042835 .

PMID 35474242 .

v t e Encoded (proteinogenic) amino acids General topics Protein Peptide Genetic code Unspecified L-amino acid By properties Aliphatic Branched-chain amino acids ( Valine Isoleucine Leucine ) Methionine Alanine Proline Glycine Aromatic Histidine Tyrosine Tryptophan Phenylalanine Polar , uncharged Asparagine Glutamine Serine Threonine Positive charge (p K a ) Lysine (≈10.8) Arginine (≈12.5) Histidine (≈6.1) Pyrrolysine Negative charge (p K a ) Aspartic acid (≈3.9) Glutamic acid (≈4.1) Selenocysteine (≈5.4) Cysteine (≈8.3) Tyrosine (≈10.1) Amino acids types : Encoded (proteins) Essential Non-proteinogenic Ketogenic Glucogenic Secondary amino Imino acids D-amino acids Dehydroamino acids v t e Amino acid metabolism metabolic intermediates K → acetyl-CoA lysine → Saccharopine Allysine α-Aminoadipic acid 2-Oxoadipic acid Glutaryl-CoA Glutaconyl-CoA Crotonyl-CoA β-Hydroxybutyryl-CoA leucine → β-Hydroxy β-methylbutyric acid β-Hydroxy β-methylbutyryl-CoA Isovaleryl-CoA α-Ketoisocaproic acid β-Ketoisocaproic acid β-Ketoisocaproyl-CoA β-Leucine β-Methylcrotonyl-CoA β-Methylglutaconyl-CoA β-Hydroxy β-methylglutaryl-CoA tryptophan → alanine → N ′-Formylkynurenine Kynurenine Anthranilic acid 3-Hydroxykynurenine 3-Hydroxyanthranilic acid 2-Amino-3-carboxymuconic semialdehyde 2-Aminomuconic semialdehyde 2-Aminomuconic acid Glutaryl-CoA G G→ pyruvate → citrate glycine → serine → 3-Phosphoglyceric acid glycine → creatine : Glycocyamine Phosphocreatine Creatinine G→ glutamate → α-ketoglutarate histidine → Urocanic acid Imidazol-4-one-5-propionic acid Formiminoglutamic acid Glutamate-1-semialdehyde proline → 1-Pyrroline-5-carboxylic acid arginine → Agmatine Ornithine Citrulline Cadaverine Putrescine other cysteine + glutamate → glutathione : γ-Glutamylcysteine G→ propionyl-CoA → succinyl-CoA valine → α-Ketoisovaleric acid Isobutyryl-CoA Methacrylyl-CoA 3-Hydroxyisobutyryl-CoA 3-Hydroxyisobutyric acid 2-Methyl-3-oxopropanoic acid isoleucine → 2,3-Dihydroxy-3-methylpentanoic acid 2-Methylbutyryl-CoA Tiglyl-CoA 2-Methylacetoacetyl-CoA methionine → generation of homocysteine : S -Adenosyl methionine S -Adenosyl- L -homocysteine Homocysteine conversion to cysteine : Cystathionine α-Ketobutyric acid + Cysteine threonine → α-Ketobutyric acid propionyl-CoA → Methylmalonyl-CoA G→ fumarate phenylalanine → tyrosine → 4-Hydroxyphenylpyruvic acid Homogentisic acid 4-Maleylacetoacetic acid G→ oxaloacetate see urea cycle Other Cysteine metabolism Cysteine sulfinic acid v t e Neurotransmitters Amino acid -derived Major excitatory / inhibitory systems Glutamate system Agmatine Aspartic acid (aspartate) Glutamic acid (glutamate) Glutathione Glycine GSNO GSSG Kynurenic acid NAA NAAG Proline Serine GABA system GABA GABOB GHB Glycine system α-Alanine β-Alanine Glycine Hypotaurine Proline Sarcosine Serine Taurine GHB system GHB T-HCA (GHC) Biogenic amines Monoamines 6-OHM Dopamine Epinephrine (adrenaline) NAS (normelatonin) Norepinephrine (noradrenaline) Serotonin (5-HT) Trace amines 3-Iodothyronamine N-Methylphenethylamine N-Methyltryptamine m -Octopamine p -Octopamine Phenylethanolamine Phenethylamine Synephrine Tryptamine m -Tyramine p -Tyramine Others Histamine Neuropeptides See here instead.

Lipid -derived Endocannabinoids 2-AG 2-AGE (noladin ether) 2-ALPI 2-OG AA-5-HT Anandamide (AEA) DEA LPI NADA NAGly OEA Oleamide PEA RVD-Hpα SEA Virodhamine (O-AEA) Neurosteroids See here instead.

Nucleobase -derived Nucleosides Adenosine system ADP AMP ATP Vitamin -derived Miscellaneous Cholinergic system Acetylcholine Gasotransmitters Carbon monoxide (CO) Hydrogen sulfide (H 2 S) Nitric oxide (NO) Candidates Acetaldehyde Ammonia (NH 3 ) Carbonyl sulfide (COS) Nitrous oxide (N 2 O) Sulfur dioxide (SO 2 ) v t e Ionotropic glutamate receptor modulators AMPAR Tooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor Agonists: Main site agonists: 5-Fluorowillardiine Acromelic acid (acromelate) AMPA BOAA Domoic acid Glutamate Ibotenic acid Proline Quisqualic acid Willardiine ; Positive allosteric modulators: Aniracetam Cyclothiazide CX-516 CX-546 CX-614 Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942 Diazoxide Hydrochlorothiazide (HCTZ) IDRA-21 LY-392098 LY-395153 LY-404187 LY-451646 LY-503430 Mibampator (LY-451395) Nooglutyl ORG-26576 Oxiracetam PEPA Pesampator (BIIB-104, PF-04958242) Piracetam Pramiracetam S-18986 Tulrampator (S-47445, CX-1632) Antagonists: ACEA-1011 ATPO Becampanel Caroverine CNQX Dasolampanel DNQX Fanapanel (MPQX) GAMS Kaitocephalin Kynurenic acid Kynurenine Licostinel (ACEA-1021) NBQX PNQX Selurampanel Tezampanel Theanine Topiramate YM90K Zonampanel ; Negative allosteric modulators: Barbiturates (e.g., pentobarbital , sodium thiopental ) Cyclopropane Enflurane Ethanol (alcohol) Evans blue GYKI-52466 GYKI-53655 Halothane Irampanel Isoflurane Perampanel Pregnenolone sulfate Sevoflurane Talampanel ; Unknown/unsorted antagonists: Minocycline KAR Tooltip Kainate receptor Agonists: Main site agonists: 5-Bromowillardiine 5-Iodowillardiine Acromelic acid (acromelate) AMPA ATPA Domoic acid Glutamate Ibotenic acid Kainic acid LY-339434 Proline Quisqualic acid SYM-2081 ; Positive allosteric modulators: Cyclothiazide Diazoxide Enflurane Halothane Isoflurane Antagonists: ACEA-1011 CNQX Dasolampanel DNQX GAMS Kaitocephalin Kynurenic acid Licostinel (ACEA-1021) LY-382884 NBQX NS102 Selurampanel Tezampanel Theanine Topiramate UBP-302 ; Negative allosteric modulators: Barbiturates (e.g., pentobarbital , sodium thiopental ) Enflurane Ethanol (alcohol) Evans blue NS-3763 Pregnenolone sulfate NMDAR Tooltip N-Methyl-D-aspartate receptor Agonists: Main site agonists: AMAA Aspartate Glutamate Homocysteic acid ( L -HCA) Homoquinolinic acid Ibotenic acid NMDA Proline Quinolinic acid Tetrazolylglycine Theanine ; Glycine site agonists: β-Fluoro- D -alanine ACBD ACC (ACPC) ACPD AK-51 Apimostinel (NRX-1074) B6B21 CCG D -Alanine D -Cycloserine D -Serine DHPG Dimethylglycine Glycine HA-966 L-687,414 L -Alanine L -Serine Milacemide Neboglamine (nebostinel) Rapastinel (GLYX-13) Sarcosine ; Polyamine site agonists: Neomycin Spermidine Spermine ; Other positive allosteric modulators: 24 S -Hydroxycholesterol DHEA Tooltip Dehydroepiandrosterone ( prasterone ) DHEA sulfate ( prasterone sulfate ) Epipregnanolone sulfate Plazinemdor Pregnenolone sulfate SAGE-201 SAGE-301 SAGE-718 Antagonists: Competitive antagonists: AP5 (APV) AP7 CGP-37849 CGP-39551 CGP-39653 CGP-40116 CGS-19755 CPP Kaitocephalin LY-233053 LY-235959 LY-274614 MDL-100453 Midafotel (d-CPPene) NPC-12626 NPC-17742 PBPD PEAQX Perzinfotel PPDA SDZ-220581 Selfotel ; Glycine site antagonists: 4-Cl-KYN (AV-101) 5,7-DCKA 7-CKA ACC ACEA-1011 ACEA-1328 Apimostinel (NRX-1074) AV-101 Carisoprodol CGP-39653 CNQX D -Cycloserine DNQX Felbamate Gavestinel GV-196771 Harkoseride Kynurenic acid Kynurenine L-689560 L-701324 Licostinel (ACEA-1021) LU-73068 MDL-105519 Meprobamate MRZ 2/576 PNQX Rapastinel (GLYX-13) ZD-9379 ; Polyamine site antagonists: Arcaine Co 101676 Diaminopropane Diethylenetriamine Huperzine A Putrescine ; Uncompetitive pore blockers (mostly dizocilpine site): 2-MDP 3-HO-PCP 3-MeO-PCE 3-MeO-PCMo 3-MeO-PCP 4-MeO-PCP 8A-PDHQ 18-MC α-Endopsychosin Alaproclate Alazocine (SKF-10047) Amantadine Aptiganel Argiotoxin-636 Arketamine ARL-12495 ARL-15896-AR ARL-16247 Budipine Coronaridine Delucemine (NPS-1506) Dexoxadrol Dextrallorphan Dextromethadone Dextromethorphan Dextrorphan Dieticyclidine Diphenidine Dizocilpine Ephenidine Esketamine Etoxadrol Eticyclidine F-17475 Fluorolintane Gacyclidine Ibogaine Ibogamine Indantadol Ketamine Ketobemidone Lanicemine Levomethadone Levomethorphan Levomilnacipran Levorphanol Loperamide Memantine Methadone Methorphan Methoxetamine Methoxphenidine Milnacipran Morphanol NEFA Neramexane Nitromemantine Noribogaine Norketamine Orphenadrine PCPr PD-137889 Pethidine (meperidine) Phencyclamine Phencyclidine Propoxyphene Remacemide Rhynchophylline Rimantadine Rolicyclidine Sabeluzole Tabernanthine Tenocyclidine Tiletamine Tramadol ; Ifenprodil (NR2B) site antagonists: Besonprodil Buphenine (nylidrin) CO-101244 (PD-174494) Eliprodil Haloperidol Isoxsuprine Radiprodil (RGH-896) Rislenemdaz (CERC-301, MK-0657) Ro 8-4304 Ro 25-6981 Safaprodil Traxoprodil (CP-101606) ; NR2A-selective antagonists: MPX-004 MPX-007 TCN-201 TCN-213 ; Cations: Hydrogen Magnesium Zinc ; Alcohols/volatile anesthetics/related: Benzene Butane Chloroform Cyclopropane Desflurane Diethyl ether Enflurane Ethanol (alcohol) Halothane Hexanol Isoflurane Methoxyflurane Nitrous oxide Octanol Sevoflurane Toluene Trichloroethane Trichloroethanol Trichloroethylene Urethane Xenon Xylene ; Unknown/unsorted antagonists: ARR-15896 Bumetanide Caroverine Conantokin D -αAA Dexanabinol Flufenamic acid Flupirtine FPL-12495 FR-115427 Furosemide Hodgkinsine Ipenoxazone (MLV-6976) MDL-27266 Metaphit Minocycline MPEP Niflumic acid Pentamidine Pentamidine isethionate Piretanide Psychotridine Transcrocetin ( saffron ) Unsorted: Allosteric modulators: AGN-241751 See also: Receptor/signaling modulators Metabotropic glutamate receptor modulators Glutamate metabolism/transport modulators v t e Glycine receptor modulators Receptor ( ligands ) GlyR Tooltip Glycine receptor Agonists: β-Alanine β-ABA (BABA) β-AIBA Caesium D -Alanine D -Serine GABA Glycine Hypotaurine Ivermectin L -Alanine L -Proline L -Serine L -Threonine MDL-27531 Milacemide Picolinic acid Propofol Quisqualamine Sarcosine Taurine Positive modulators: Alcohols (e.g., brometone , chlorobutanol (chloretone) , ethanol (alcohol) , tert -butanol (2M2P) , tribromoethanol , trichloroethanol , trifluoroethanol ) Alkylbenzene sulfonate Anandamide Barbiturates (e.g., pentobarbital , sodium thiopental ) Chlormethiazole D12-116 Dihydropyridines (e.g., nicardipine ) Etomidate Ginseng constituents (e.g., ginsenosides (e.g., ginsenoside-Rf )) Glutamic acid (glutamate) Ivermectin Ketamine Neuroactive steroids (e.g., alfaxolone , pregnenolone (eltanolone) , pregnenolone acetate , minaxolone , ORG-20599 ) Nitrous oxide Penicillin G Propofol Tamoxifen Tetrahydrocannabinol Triclofos Tropeines (e.g., atropine , bemesetron , cocaine , LY-278584 , tropisetron , zatosetron ) Volatiles / gases (e.g., chloral hydrate , chloroform , desflurane , diethyl ether (ether) , enflurane , halothane , isoflurane , methoxyflurane , sevoflurane , toluene , trichloroethane (methyl chloroform) , trichloroethylene ) Xenon Zinc Antagonists: 2-Aminostrychnine 2-Nitrostrychnine 4-Phenyl-4-formyl-N-methylpiperidine αEMBTL Bicuculline Brucine Cacotheline Caffeine Colchicine Colubrine Cyanotriphenylborate Dendrobine Diaboline Endocannabinoids (e.g., 2-AG , anandamide (AEA) ) Gaboxadol (THIP) Gelsemine iso-THAZ Isobutyric acid Isonipecotic acid Isostrychnine Laudanosine N-Methylbicuculline N-Methylstrychnine N,N-Dimethylmuscimol Nipecotic acid Pitrazepin Pseudostrychnine Quinolines (e.g., 4-hydroxyquinoline , 4-hydroxyquinoline-3-carboxylic acid , 5,7-CIQA , 7-CIQ , 7-TFQ , 7-TFQA ) RU-5135 Sinomenine Strychnine Thiocolchicoside Tutin Negative modulators: Amiloride Benzodiazepines (e.g., bromazepam , clonazepam , diazepam , flunitrazepam , flurazepam ) Corymine Cyanotriphenylborate Daidzein Dihydropyridines (e.g., nicardipine , nifedipine , nitrendipine ) Furosemide Genistein Ginkgo constituents (e.g., bilobalide , ginkgolides (e.g., ginkgolide A , ginkgolide B , ginkgolide C , ginkgolide J , ginkgolide M )) Imipramine NBQX Neuroactive steroids (e.g., 3α-androsterone sulfate , 3β-androsterone sulfate , deoxycorticosterone , DHEA sulfate , pregnenolone sulfate , progesterone ) Opioids (e.g., codeine , dextromethorphan , dextrorphan , levomethadone , levorphanol , morphine , oripavine , pethidine , thebaine ) Picrotoxin (i.e., picrotin and picrotoxinin ) PMBA Riluzole Tropeines (e.g., bemesetron , LY-278584 , tropisetron , zatosetron ) Verapamil Zinc NMDAR Tooltip N-Methyl-D-aspartate receptor See here instead.

Transporter ( blockers ) GlyT1 Tooltip Glycine transporter 1 ACPPB ALX-5407 (NFPS) ASP2535 Bitopertin (RG1678/RO4917838) CP-802079 Ethanol (alcohol) Glycyldodecylamide GSK1018921 Iclepertin LY-2365109 Mardepodect ORG-24598 ORG-25935 (SCH-900435) Pesampator (BIIB-104, PF-04958242) PF-03463275 Sarcosine SNG-12 (Synapsinae) SSR-103,800 SSR-504,734 Tilapertin GlyT2 Tooltip Glycine transporter 2 ALX-1393 Amoxapine Ethanol (alcohol) NAGly Opiranserin (VVZ-149) ORG-25543 VVZ-368 See also Receptor/signaling modulators GABA receptor modulators GABA A receptor positive modulators Ionotropic glutamate receptor modulators Authority control databases National Germany United States Israel Other Yale LUX Retrieved from " https://en.wikipedia.org/w/index.php?title=Alanine&oldid=1301000408 " Categories : Alpha-Amino acids Proteinogenic amino acids Glucogenic amino acids Glycine receptor agonists NMDA receptor agonists Hidden categories: CS1 German-language sources (de) Articles with short description Short description is different from Wikidata Chemical articles with multiple compound IDs Chemicals using indexlabels Chemical articles with multiple CAS registry numbers Chemical articles with multiple PubChem CIDs Chemical articles with multiple ChEBIs Articles without InChI source ECHA InfoCard ID from Wikidata Chemical articles having a data page Articles containing unverified chemical infoboxes Chembox image size set Short description matches Wikidata This page was last edited on 17 July 2025, at 15:35 (UTC) .

Text is available under the Creative Commons Attribution-ShareAlike 4.0 License ;
additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy . Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.

, a non-profit organization.

Privacy policy About Wikipedia Disclaimers Contact Wikipedia Code of Conduct Developers Statistics Cookie statement Mobile view Search Search Toggle the table of contents Alanine 71 languages Add topic

